Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction

Gaetano M. de Ferrari, Massimo Mantica, Emilio Vanoli, Stephen S. Hull, Peter J. Schwartz

Research output: Contribution to journalArticle

Abstract

Objectives. The goal of this study was to assess the hypothesis that transdermal scopolamine would increase vagal activity in patients after myocardial infarction. Background. In postmyocardial infarction patients, low heart rate variability and reduced baroreceptor reflex sensitivity are associated with increased mortality. Accordingly, there is an increasing interest in a mechanism for shifting the sympathovagal balance toward vagal dominance. Methods. The effects of transdermal administration of scopolamine on heart rate variability and baroreceptor reflex sensitivity were assessed in 20 patients (mean age 59 ± 11 years) by pharmacologic washout 14 ± 3 days after myocardial infarction. Heart rate variability and baroreceptor reflex sensitivity were measured 24 h after application of the scopolamine patch and compared with the values measured before scopolamine and after application of a placebo patch. The following variables were derived from a 15-min electrocardiographic recording: the mean RR interval and its standard deviation, the mean square successive difference, the percent of intervals differing >50 ms from the preceding RR interval and the low and high frequency areas resulting from power spectral analysis. Results. The placebo patch had no effect on the variables measured. Scopolamine increased both heart rate variability and baroreceptor reflex sensitivity significantly. Specifically, the mean RR interval and its standard deviation increased by 7.1% (p = 0.01) and 25% (p = 0.004), respectively. The mean square successive difference increased by 38% (p = 0.0003) and the percent of intervals differing >50 ms from the preceding interval by 100% (p = 0.001). The ratio of low to high frequency areas of the power spectrum decreased by 24% (p = 0.02), and baroreceptor reflex sensitivity increased by 42% (p = 0.0006). These effects were also evident in patients with very low initial values. Side effects were minimal. Conclusions. Transdermal scopolamine increased measures of heart rate variability and baroreceptor reflex sensitivity in patients with a recent myocardial infarction toward values associated with a better prognosis. Pharmacologic modulation of the autonomic balance by scopolamine or related drugs deserves evaluation as a new and promising approach to reduce risk after myocardial infarction.

Original languageEnglish
Pages (from-to)1327-1334
Number of pages8
JournalJournal of the American College of Cardiology
Volume22
Issue number5
DOIs
Publication statusPublished - Nov 1 1993

Fingerprint

Scopolamine Hydrobromide
Baroreflex
Reflex
Myocardial Infarction
Heart Rate
Placebos
Cutaneous Administration
Drug Evaluation
Infarction
Mortality

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. / de Ferrari, Gaetano M.; Mantica, Massimo; Vanoli, Emilio; Hull, Stephen S.; Schwartz, Peter J.

In: Journal of the American College of Cardiology, Vol. 22, No. 5, 01.11.1993, p. 1327-1334.

Research output: Contribution to journalArticle

@article{84cce59274164f97ba98ae0599de6dc6,
title = "Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction",
abstract = "Objectives. The goal of this study was to assess the hypothesis that transdermal scopolamine would increase vagal activity in patients after myocardial infarction. Background. In postmyocardial infarction patients, low heart rate variability and reduced baroreceptor reflex sensitivity are associated with increased mortality. Accordingly, there is an increasing interest in a mechanism for shifting the sympathovagal balance toward vagal dominance. Methods. The effects of transdermal administration of scopolamine on heart rate variability and baroreceptor reflex sensitivity were assessed in 20 patients (mean age 59 ± 11 years) by pharmacologic washout 14 ± 3 days after myocardial infarction. Heart rate variability and baroreceptor reflex sensitivity were measured 24 h after application of the scopolamine patch and compared with the values measured before scopolamine and after application of a placebo patch. The following variables were derived from a 15-min electrocardiographic recording: the mean RR interval and its standard deviation, the mean square successive difference, the percent of intervals differing >50 ms from the preceding RR interval and the low and high frequency areas resulting from power spectral analysis. Results. The placebo patch had no effect on the variables measured. Scopolamine increased both heart rate variability and baroreceptor reflex sensitivity significantly. Specifically, the mean RR interval and its standard deviation increased by 7.1{\%} (p = 0.01) and 25{\%} (p = 0.004), respectively. The mean square successive difference increased by 38{\%} (p = 0.0003) and the percent of intervals differing >50 ms from the preceding interval by 100{\%} (p = 0.001). The ratio of low to high frequency areas of the power spectrum decreased by 24{\%} (p = 0.02), and baroreceptor reflex sensitivity increased by 42{\%} (p = 0.0006). These effects were also evident in patients with very low initial values. Side effects were minimal. Conclusions. Transdermal scopolamine increased measures of heart rate variability and baroreceptor reflex sensitivity in patients with a recent myocardial infarction toward values associated with a better prognosis. Pharmacologic modulation of the autonomic balance by scopolamine or related drugs deserves evaluation as a new and promising approach to reduce risk after myocardial infarction.",
author = "{de Ferrari}, {Gaetano M.} and Massimo Mantica and Emilio Vanoli and Hull, {Stephen S.} and Schwartz, {Peter J.}",
year = "1993",
month = "11",
day = "1",
doi = "10.1016/0735-1097(93)90538-C",
language = "English",
volume = "22",
pages = "1327--1334",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction

AU - de Ferrari, Gaetano M.

AU - Mantica, Massimo

AU - Vanoli, Emilio

AU - Hull, Stephen S.

AU - Schwartz, Peter J.

PY - 1993/11/1

Y1 - 1993/11/1

N2 - Objectives. The goal of this study was to assess the hypothesis that transdermal scopolamine would increase vagal activity in patients after myocardial infarction. Background. In postmyocardial infarction patients, low heart rate variability and reduced baroreceptor reflex sensitivity are associated with increased mortality. Accordingly, there is an increasing interest in a mechanism for shifting the sympathovagal balance toward vagal dominance. Methods. The effects of transdermal administration of scopolamine on heart rate variability and baroreceptor reflex sensitivity were assessed in 20 patients (mean age 59 ± 11 years) by pharmacologic washout 14 ± 3 days after myocardial infarction. Heart rate variability and baroreceptor reflex sensitivity were measured 24 h after application of the scopolamine patch and compared with the values measured before scopolamine and after application of a placebo patch. The following variables were derived from a 15-min electrocardiographic recording: the mean RR interval and its standard deviation, the mean square successive difference, the percent of intervals differing >50 ms from the preceding RR interval and the low and high frequency areas resulting from power spectral analysis. Results. The placebo patch had no effect on the variables measured. Scopolamine increased both heart rate variability and baroreceptor reflex sensitivity significantly. Specifically, the mean RR interval and its standard deviation increased by 7.1% (p = 0.01) and 25% (p = 0.004), respectively. The mean square successive difference increased by 38% (p = 0.0003) and the percent of intervals differing >50 ms from the preceding interval by 100% (p = 0.001). The ratio of low to high frequency areas of the power spectrum decreased by 24% (p = 0.02), and baroreceptor reflex sensitivity increased by 42% (p = 0.0006). These effects were also evident in patients with very low initial values. Side effects were minimal. Conclusions. Transdermal scopolamine increased measures of heart rate variability and baroreceptor reflex sensitivity in patients with a recent myocardial infarction toward values associated with a better prognosis. Pharmacologic modulation of the autonomic balance by scopolamine or related drugs deserves evaluation as a new and promising approach to reduce risk after myocardial infarction.

AB - Objectives. The goal of this study was to assess the hypothesis that transdermal scopolamine would increase vagal activity in patients after myocardial infarction. Background. In postmyocardial infarction patients, low heart rate variability and reduced baroreceptor reflex sensitivity are associated with increased mortality. Accordingly, there is an increasing interest in a mechanism for shifting the sympathovagal balance toward vagal dominance. Methods. The effects of transdermal administration of scopolamine on heart rate variability and baroreceptor reflex sensitivity were assessed in 20 patients (mean age 59 ± 11 years) by pharmacologic washout 14 ± 3 days after myocardial infarction. Heart rate variability and baroreceptor reflex sensitivity were measured 24 h after application of the scopolamine patch and compared with the values measured before scopolamine and after application of a placebo patch. The following variables were derived from a 15-min electrocardiographic recording: the mean RR interval and its standard deviation, the mean square successive difference, the percent of intervals differing >50 ms from the preceding RR interval and the low and high frequency areas resulting from power spectral analysis. Results. The placebo patch had no effect on the variables measured. Scopolamine increased both heart rate variability and baroreceptor reflex sensitivity significantly. Specifically, the mean RR interval and its standard deviation increased by 7.1% (p = 0.01) and 25% (p = 0.004), respectively. The mean square successive difference increased by 38% (p = 0.0003) and the percent of intervals differing >50 ms from the preceding interval by 100% (p = 0.001). The ratio of low to high frequency areas of the power spectrum decreased by 24% (p = 0.02), and baroreceptor reflex sensitivity increased by 42% (p = 0.0006). These effects were also evident in patients with very low initial values. Side effects were minimal. Conclusions. Transdermal scopolamine increased measures of heart rate variability and baroreceptor reflex sensitivity in patients with a recent myocardial infarction toward values associated with a better prognosis. Pharmacologic modulation of the autonomic balance by scopolamine or related drugs deserves evaluation as a new and promising approach to reduce risk after myocardial infarction.

UR - http://www.scopus.com/inward/record.url?scp=0027361512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027361512&partnerID=8YFLogxK

U2 - 10.1016/0735-1097(93)90538-C

DO - 10.1016/0735-1097(93)90538-C

M3 - Article

C2 - 8227788

AN - SCOPUS:0027361512

VL - 22

SP - 1327

EP - 1334

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 5

ER -